Imeik Technology Development Co.,Ltd. Imeik Technology Development Co.,Ltd.

Imeik Technology Development Co.,Ltd.

300896

Rank in Stocks #3853
Imeik Technology Development Co.,Ltd. specializes in the research, development,... Imeik Technology Development Co.,Ltd. specializes in the research, development, manufacturing, and distribution of biomedical materials. The company's diverse product portfolio caters to both the medical aesthetics field and general skincare needs. Within its medical beauty offerings, Imeik provides a range of recognized brands including Moisten Angel, IFRESH, Yimei, Hearty, Bonita Bonita, and Tightly. Additionally, its comprehensive skincare line features hydrating lotions, anti-aging and firming serums, concentrated essence creams, revitalizing facial masks, restorative chitosan B5 sprays, and clarifying and illuminating liquids. Established in 2004, the company's operations are based in Beijing, China.
Share Price
$14.24
Market Cap
$4.31B
Change (1 day)
-0.62%
Change (1 year)
-39.56%
Country
CN
Trade Imeik Technology Development Co.,Ltd. (300896)

Category

Healthcare
Earnings for Imeik Technology Development Co.,Ltd. (300896)
Earnings in Jun 2026 TTM: $187.62M
According to Imeik Technology Development Co.,Ltd. latest financial reports the company's current earnings are $187.62M. In 2023 the company made an earning of $304.52M, an increase over its 2022 earnings that were of $215.76M. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Imeik Technology Development Co.,Ltd. from 2014 to 2026
Earnings at the end of each year
Year Earnings Change
2026 (TTM) $187.62M -39.96%
2024 $312.51M 2.62%
2023 $304.52M 41.14%
2022 $215.76M 22.24%
2021 $176.50M 129.39%
2020 $76.94M 52.74%
2019 $50.38M 142.00%
2018 $20.82M 44.54%
2017 $14.40M 57.61%
2016 $9.14M 113.72%
2015 $4.28M -22.82%
2014 $5.54M 0.00%
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
$3.81B 1,928.49%
US
$4.11B 2,090.02%
FR
- -
JP
$1.59B 747.47%
US
- -
CH